Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")
Launched by ANM ADAPTIVE NEUROMODULATION GMBH · Sep 15, 2011
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Main Inclusion Criteria:
- • symptomatic subjective tonal chronical (\> 3 months) tinnitus
- • \<60dB hearing loss
- • men and women ≥18 years old
- Main Exclusion Criteria:
- • serious neurologic
- • psychiatric or internistic disease
- • objective tinnitus
- • Morbus Menière
- • craniomandibular triggered tinnitus
About Anm Adaptive Neuromodulation Gmbh
ANM Adaptive Neuromodulation GmbH is a pioneering clinical trial sponsor focused on advancing innovative neuromodulation therapies to enhance the treatment of neurological disorders. Leveraging cutting-edge research and technology, ANM specializes in the development of adaptive stimulation solutions tailored to individual patient needs. The company's commitment to rigorous scientific methodology and ethical standards ensures the integrity and reliability of its clinical trials. By collaborating with leading medical institutions and researchers, ANM aims to transform patient outcomes and contribute to the evolving landscape of neuromodulation therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augsburg, , Germany
Bad Bramstedt, , Germany
Berlin, , Germany
Berlin, , Germany
Braunschweig, , Germany
Frankfurt, , Germany
Freiburg, , Germany
Fuerth, , Germany
Grevenbroich, , Germany
Halle/Saale, , Germany
Koblenz, , Germany
Koeln, , Germany
Krefeld, , Germany
Mainz, , Germany
Mannheim, , Germany
Meerbusch, , Germany
Melsungen, , Germany
Muenchen, , Germany
Nuertingen, , Germany
Oelde, , Germany
Philippsburg, , Germany
Radevormwald, , Germany
Schweinfurt, , Germany
Patients applied
Trial Officials
Uwe Brinkmann, Dr. med.
Principal Investigator
HNO-Gemeinschaftspraxis Hamm-Ahlen-Oelde
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials